HOPRUVI
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79279302 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2020-01-13 | Application Filed |
| 2020-02-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-02-20 | Status: Live/Pending |
| 2020-02-25 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Entity Statement | Registered Company |
| Address | 980 Great West Road Brentford, Middlesex TW8 9GS GB |
| Legal Entity Type | |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-02-20 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2020-02-24 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-02-25 | 3 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2020-02-29 | 4 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-03-15 | 5 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-03-18 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-03-19 | 7 RFCR E:E-Mail |
| DEATH OF INTERNATIONAL REGISTRATION | 2020-04-02 | 8 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2020-04-03 | 9 DENA O:Outgoing Correspondence |
| REFUSAL PROCESSED BY MPU | 2020-04-05 | 10 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-04-05 | 11 RFCS P: |
| IRREGULARITY ON REFUSAL FROM IB | 2020-04-28 | 12 IRRF M: |
| IRREGULARITY FROM IB EXAMINED BY MPU | 2020-04-29 | 13 IRRH M: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 